Royal Bank of Canada’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-150,000
| Closed | -$17.3M | – | 7379 |
|
|
2023
Q2 | $17.3M | Buy |
150,000
+149,400
| +24,900% | +$17M | ﹤0.01% | 1232 |
|
|
2023
Q1 | $64K | Sell |
600
-484,300
| -100% | -$52.3M | ﹤0.01% | 5484 |
|
|
2022
Q4 | $53.8M | Buy |
484,900
+404,600
| +504% | +$41.4M | 0.02% | 658 |
|
|
2022
Q3 | $6.92M | Buy |
80,300
+4,300
| +6% | +$384K | ﹤0.01% | 1818 |
|
|
2022
Q2 | $6.93M | Hold |
76,000
| – | – | ﹤0.01% | 1849 |
|
|
2022
Q1 | $6.24M | Sell |
76,000
-65,000
| -46% | -$5.12M | ﹤0.01% | 2072 |
|
|
2021
Q4 | $10.8M | Buy |
141,000
+21,000
| +18% | +$1.67M | ﹤0.01% | 1828 |
|
|
2021
Q3 | $9.01M | Buy |
120,000
+75,000
| +167% | +$5.7M | ﹤0.01% | 1900 |
|
|
2021
Q2 | $3.5M | Sell |
45,000
-235,340
| -84% | -$17.5M | ﹤0.01% | 2568 |
|
|
2021
Q1 | $20.6M | Sell |
280,340
-156,781
| -36% | -$11.6M | 0.01% | 1254 |
|
|
2020
Q4 | $34.1M | Buy |
437,121
+305,597
| +232% | +$23.4M | 0.01% | 903 |
|
|
2020
Q3 | $10.4M | Buy |
131,524
+83,840
| +176% | +$6.57M | ﹤0.01% | 1517 |
|
|
2020
Q2 | $3.52M | Buy |
+47,684
| New | +$3.59M | ﹤0.01% | 2188 |
|
|
2020
Q1 | – | Sell |
-251,730
| Closed | -$21.8M | – | 6897 |
|
|
2019
Q4 | $21.8M | Buy |
251,730
+210
| +0.1% | +$17.2K | 0.01% | 1106 |
|
|
2019
Q3 | $20.2M | Sell |
251,520
-43,702
| -15% | -$3.5M | 0.01% | 1081 |
|
|
2019
Q2 | $23.6M | Buy |
295,222
+315
| +0.1% | +$24.1K | 0.01% | 980 |
|
|
2019
Q1 | $23.4M | Sell |
294,907
-79,229
| -21% | -$5.93M | 0.01% | 963 |
|
|
2018
Q4 | $27.3M | Buy |
374,136
+2,096
| +0.6% | +$148K | 0.01% | 817 |
|
|
2018
Q3 | $25.2M | Sell |
372,040
-46,426
| -11% | -$2.96M | 0.01% | 974 |
|
|
2018
Q2 | $24.2M | Sell |
418,466
-26,200
| -6% | -$1.48M | 0.01% | 952 |
|
|
2018
Q1 | $23.1M | Sell |
444,666
-288,410
| -39% | -$15.6M | 0.01% | 995 |
|
|
2017
Q4 | $39.4M | Buy |
733,076
+309,160
| +73% | +$17.1M | 0.02% | 737 |
|
|
2017
Q3 | $25.9M | Hold |
423,916
| – | – | 0.01% | 942 |
|
|
2017
Q2 | $25.9M | Buy |
423,916
+26,200
| +7% | +$1.59M | 0.01% | 890 |
|
|
2017
Q1 | $24.1M | Sell |
397,716
-477,993
| -55% | -$29M | 0.01% | 910 |
|
|
2016
Q4 | $49.2M | Sell |
875,709
-459,757
| -34% | -$26.9M | 0.03% | 518 |
|
|
2016
Q3 | $79.5M | Buy |
1,335,466
+76,713
| +6% | +$4.49M | 0.04% | 337 |
|
|
2016
Q2 | $69.2M | Buy |
1,258,753
+125,236
| +11% | +$6.67M | 0.04% | 353 |
|
|
2016
Q1 | $57.2M | Buy |
1,133,517
+6,707
| +0.6% | +$328K | 0.04% | 410 |
|
|
2015
Q4 | $56.8M | Buy |
1,126,810
+12,576
| +1% | +$634K | 0.04% | 398 |
|
|
2015
Q3 | $52.5M | Buy |
1,114,234
+417,314
| +60% | +$22.2M | 0.04% | 341 |
|
|
2015
Q2 | $37.9M | Buy |
696,920
+299,309
| +75% | +$16.8M | 0.03% | 495 |
|
|
2015
Q1 | $21.8M | Buy |
397,611
+95,263
| +32% | +$5.39M | 0.02% | 768 |
|
|
2014
Q4 | $16.4M | Buy |
302,348
+249,948
| +477% | +$13.9M | 0.01% | 961 |
|
|
2014
Q3 | $2.96M | Sell |
52,400
-97,464
| -65% | -$5.47M | ﹤0.01% | 2005 |
|
|
2014
Q2 | $8.27M | Buy |
149,864
+97,464
| +186% | +$5.32M | 0.01% | 1322 |
|
|
2014
Q1 | $2.84M | Buy |
+52,400
| New | +$2.71M | ﹤0.01% | 1998 |
|
|
2013
Q4 | – | Sell |
-118,843
| Closed | -$5.4M | – | 6060 |
|
|
2013
Q3 | $5.4M | Sell |
118,843
-1,042,760
| -90% | -$47.6M | ﹤0.01% | 1534 |
|
|
2013
Q2 | $51.5M | Buy |
+1,161,603
| New | +$51.9M | 0.04% | 310 |
|
Other funds holding MRK
VCM
VPM
Royal Bank of Canada's MRK Position: Q1 2026 in Review
Royal Bank of Canada increased its Merck (MRK) stake by 0.09% in Q1 2026, buying an estimated $1.34M and bringing the position to 13,201,722 shares worth $1.59B. The position accounts for 0.28% of the portfolio, ranked #67.
Royal Bank of Canada first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.94B in Q2 2024. 3,789 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Royal Bank of Canada held 13,201,722 shares of Merck worth $1.59B as of Q1 2026.
- Royal Bank of Canada bought 11,637 Merck shares in Q1 2026, an estimated $1.34M.
- Merck made up 0.28% of Royal Bank of Canada's portfolio in Q1 2026, its #67 holding.
- Royal Bank of Canada first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Merck position peaked at $1.94B in Q2 2024.
- 3,789 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.